SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (6717)4/9/1998 11:16:00 AM
From: 4 - Bob  Read Replies (1) of 23519
 
VLAD,

What do you make of the following paragraph taken from the business wire indicated below:

VIVUS Reports First Quarter Results
BusinessWire, Thursday, April 09, 1998 at 07:47
MOUNTAIN VIEW, Calif.--(BW HealthWire)--April 9, 1998--VIVUS Inc

...
Also, during the quarter, VIVUS received Food and Drug
Administration (FDA) approval of the finished packaging area contained
within its new facility located in Lakewood, New Jersey. Approval of
this operations area will allow the Company to transfer the final
packaging of US commercial product from the current contract
facilities to high speed, automated equipment in the new plant. This
efficiency should result in cost savings to the Company.
...

The paragraph state that Vivus "RECEIVED" FDA approval during the quarter. Could this be a typo or are there more than one pending FDA approval for the new plant and/or its operations?

Live long & Prosper,
4-BOB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext